在小鼠模型中,RTS,S/AS01疟疾疫苗保护性抗体值与抗原和辅助剂剂量相关
Christopher J Genito1, Katherine Brooks1, Alexis Smith1
1Structural Vaccinology Laboratory, Biologics Research and Development Branch, Walter Reed Army Institute of Research, Silver Spring, MD, 20910, USA.
NPJ vaccines
|August 10, 2023
概括
疟疾疫苗候选者RTS,S/AS01在小鼠模型中显示出高无菌保护. 优化抗原和辅助剂剂量提高了疗效,建议改进疟疾疫苗开发策略.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 寄生虫学的寄生虫学
背景情况:
- 鼠标模型对于评估疟疾疫苗候选人至关重要.
- 疟原 (Plasmodium falciparum circumsporozoite) 蛋白质 (CSP) 是疟疾疫苗的一个关键标.
- 吉斯凯公司的RTS,S/AS01疫苗已证明在预防疟疾方面具有有效性.
研究的目的:
- 评估RTS,S/AS01疟疾疫苗在转基因Plasmodium berghei sporozoite挑战小鼠模型中的有效性.
- 调查抗原剂量节约效应,并将RTS,S/AS01与可溶性CSP抗原进行比较.
- 探索抗原和辅助剂定位对疫苗诱导的免疫和保护的影响.
主要方法:
- 使用了一个转基因的Plasmodium berghei sporozoite挑战小鼠模型.
- 对RTS,S抗原进行了剂量定位研究,使用固定的AS01辅助剂量.
- 研究了RTS,S抗原和AS01辅助剂的联合定位.
主要成果:
- 在小鼠模型中,RTS,S/AS01诱导了高水平的无菌保护.
- 证明了显著的抗原剂量节约效应,其中RTS,S/AS01的性能优于可溶性CSP.
- 确定了与保护性免疫相关的主要重复抗体标位的值.
- 减少辅助剂量改善了抗体增强,并降低了第三次接种疫苗后的保护性抗体值.
结论:
- 优化的小鼠模型有效地评估了疟疾疫苗的有效性.
- 抗原剂量节约和战略辅助剂的使用有望改善基于CSP的疟疾疫苗.
- 在小鼠模型中进行临床前评估可以指导下一代疟疾疫苗的开发.
更多相关视频
相关概念视频
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:28Rabies
Rabies is a lethal zoonotic disease caused by a single-stranded, negative-sense RNA virus of the Lyssavirus genus, within the family Rhabdoviridae. Its primary mode of transmission to humans is through bites or saliva-contaminated scratches from infected mammals such as dogs, bats, raccoons, or foxes. Transmission can also occur if infectious saliva contacts abraded skin or intact mucous membranes, including the conjunctiva.Viral Entry and Early ReplicationOnce introduced at the bite or scratch...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...